éå»1ã¶æéã«Anavex Life Sciences Corpã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã1åã«åºã¥ãããŒã¿ã
仿ãAVXLã¯1ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããAVXLã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯20.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS 0.084ã«ç¶ããAVXLã®FY2026Q4ã®EPSã¯-0.110ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.08 ã§ããããAnavex Life Sciences CorpAVXL ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.06 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.11 ãšäºæ³ãããŸãã